Spryng™ with OsteoCushion™ Technology
Spryng™ with OsteoCushion™ Technology is only available for use by or on the order of a licensed veterinarian.
Spryng™ with OsteoCushion™ Technology is an intra-articular injectable veterinary medical device that promotes restoration of proper joint mechanics by adding natural, viscosolid matrices to the joint’s synovial fluid. Spryng is composed of a protein-carbohydrate matrix made from purified, natural biomaterials using a proprietary, patented process.
Spryng is indicated for horses, dogs, and cats to aid in the management of noninfectious sources of joint pain including, but not limited to, degenerative joint disease, osteoarthritis, joint instability, and lameness. See package insert for complete product details.
Veterinarian pricing
Create Account or Sign In to see price
Couldn't load pickup availability
Shipping & Returns
Shipping & Returns
Shipping: PetVivo fulfills orders same or next business day (Monday-Friday), excluding Holidays.
Return Policy: Due to the nature of PetVivo’s products, product returns are not accepted. Orders received damaged, defective, non-conforming, or with incorrect items due to a PetVivo error are eligible for replacement if PetVivo is notified within 30 days of shipment. If replacement is not available for the product(s), a refund will be issued upon receipt of the product to our warehouse.
Features and Benefits
Features and Benefits
- A veterinary medical device, not a drug; offers moderation of joint pain without pharmacologic, chemical, or metabolic action
- A single treatment provides long-duration joint benefits
- Durable, sterile, hydrated biomaterial that mimics natural cartilage properties
- The viscoelastic particles in Spryng are composed of two purified proteins (collagen, elastin) and a purified carbohydrate (heparin glycan) that self-assemble to form a sterile, insoluble, and pliable matrix
- Synovial fluid is absorbed by and passes through the porous Spryng particles, integrating with the synovial fluid before slowly adsorbing onto the synovial membrane and subsequently being integrated into the subsynovial tissue
- Multiple joints may be injected as part of the same treatment
- Each unit contains 2 cc of sterile Spryng supplied in an aseptically filled, Luer-Lock syringe
- Storage: room temperature (40-90 degrees Fahrenheit)
- Up to a 26-month shelf life
